Search for Clinical Trials
A study to determine the change from baseline to post-treatment Ki67 in some breast cancer tissue.
This study is being done to evaluate the safety and effectiveness of three different drug combinations for patients with HER2-positive metastatic…
The main purpose of this study is to look at the safety and effectiveness of the standard anti-HER2-targeted therapies.
A study to determine if the combination of avelumab with several different drugs is safe and effective for treating patients with metastatic triple-…
This study is to find out if patients with HER2-positive breast cancer who have no cancer remaining at surgery after 12 weeks of chemotherapy and 2…
This study is being done to find out if tucatinib plus T-DM1 works better to treat breast cancer than T-DM1 alone.
Tucatinib is a type of drug…
The purpose of this study is to compare existing treatment with any effects of receiving 1 year of treatment with pembrolizumab after surgery.
A study to determine if the addition of atezolizumab to chemotherapy improves response in the breast and lymph nodes in patients with triple-negative…
The purpose of this study is to find out if adding simvastatin to dual anti-HER2 treatment can slow down the growth or reduce the size of your…
M16-067: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects…
